Geron Corporation Announcement: Kyowa Hakko Selects Telomerase Inhibitor Compound for Development
... potent and specific telomerase inhibitory activity in vitro and exhibits significant anti-tumor activity against multiple types of human cancer cells.......In vivo studies in rodents demonstrated activity against human malignant glioblastoma (brain cancer)....... the most pathogenic features of cancer cells is their loss of growth control, which allows tumors to invade and grow in normal tissue, causing loss of organ function and in many cases,...
Aug 13 7:32 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/bw/010813/132062.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines